A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer

Clinical trial NCT02096354 · COMPLETED

Trial details

NCT number: NCT02096354
Sponsor: EpicentRx, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2014-05-01
Primary completion: 2018-04-13
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.